Skip to main content
ZIVO
OTC Life Sciences

10% Owner Mark Strome Increases Stake in Zivo Bioscience with $195K Stock Purchase

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$10
Mkt Cap
$38.886M
52W Low
$6.953
52W High
$22.15
52W Position info
44% above low
Off High info
55% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ZIVO sits 44% above its 52-week low of $6.953.

Summary

Mark E. Strome, a 10% owner of Zivo Bioscience, acquired an additional $195,400 worth of common stock, further increasing his stake in the company.


Key Events · Ownership and Investor Activity · ZIVO

  • Significant Insider Purchase

    Mark E. Strome, a 10% owner, purchased 22,000 shares of common stock for $195,400 on February 12, 2026, at an average price of $9.77 per share.

  • Continued Insider Accumulation

    This purchase adds to a pattern of recent insider buying, following approximately $200,000 in purchases by the CEO and a Director on January 28, 2026.

  • Increased Stake

    Following this transaction, the reporting persons now indirectly hold 472,942 shares of Zivo Bioscience.


Analysis · ZIVO · Life Sciences

This significant open market purchase by a 10% owner signals continued confidence in Zivo Bioscience. The transaction, valued at $195,400, represents a notable investment relative to the company's market capitalization. This follows recent insider accumulation by the CEO and a Director in late January, reinforcing a positive trend of insider buying. Such sustained insider interest can be a bullish indicator for investors, suggesting that key stakeholders believe the stock is undervalued or that positive developments are anticipated.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 29.5% of the 1626 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ZIVO was trading at $10.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $38.9M. The 52-week trading range was $6.95 to $22.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ZIVO - Latest Insights

ZIVO
Apr 24, 2026, 6:16 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $3.30 info
Change: +$2.10 (+175%) info
Market Cap: $12.832M info
ZIVO
Mar 30, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.50
Real-time Price: $3.30 info
Change: -$3.20 (-49%) info
Market Cap: $12.832M info
ZIVO
Jan 28, 2026, 4:11 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $9.00
Real-time Price: $3.30 info
Change: -$5.70 (-63%) info
Market Cap: $12.832M info
ZIVO
Jan 28, 2026, 4:06 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $9.00
Real-time Price: $3.30 info
Change: -$5.70 (-63%) info
Market Cap: $12.832M info